(Circulation. 1999;99:2144-2149.)
© 1999 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Tulane Center for Cardiovascular Health (K.J.G., S.R.S., J.-H.X., E.D., G.S.B.) and the Department of Biostatistics and Epidemiology (L.M.), Tulane University School of Public Health and Tropical Medicine; and Department of Pediatrics (A.P.), Tulane University Medical School, New Orleans, La.
Correspondence to Gerald S. Berenson, MD, Tulane Center for Cardiovascular Health, Tulane School of Public Health and Tropical Medicine, 1501 Canal St, 14th Floor, New Orleans, LA 70112.
BackgroundElevated homocysteine is associated with increased risk for coronary artery disease (CAD) in adults, but its distribution in children is not well documented. We examined the distribution of homocysteine in children and its relation to parental history of CAD.
Methods and ResultsA subsample of 1137 children (53% white, 47% black) aged 5 to 17 years in 1992 to 1994 examined in the Bogalusa Heart Study (n=3135), including all with a positive parental history of CAD (n=154), had plasma homocysteine levels measured. Homocysteine correlated positively with age (r=0.16, P=0.001). No race or sex differences in homocysteine levels were observed; geometric mean (GM) levels were 5.8 µmol/L (95% CI, 5.6 to 6.1) among white males, 5.8 µmol/L (95% CI, 5.5 to 6.0) among white females, 5.6 µmol/L (95% CI, 5.4 to 5.8) among black males, and 5.6 µmol/L (95% CI, 5.4 to 5.9) among black females. Children with a positive parental history of CAD had a significantly greater age-adjusted GM homocysteine level (GM, 6.7 µmol/L; 95% CI, 6.4 to 7.1) than those without a positive history (GM, 5.6 µmol/L; 95% CI, 5.4 to 5.7); this relation was observed in each race-sex group.
ConclusionsHigher homocysteine levels were observed among children with a positive family history of CAD. Additional studies should elucidate the contribution of genetic, dietary, and other factors to homocysteine levels in children.
Key Words: homocysteine coronary disease pediatrics risk factors
This article has been cited by other articles:
![]() |
J. R. Ruiz, R. Sola, M. Gonzalez-Gross, F. B. Ortega, G. Vicente-Rodriguez, M. Garcia-Fuentes, A. Gutierrez, M. Sjostrom, K. Pietrzik, and M. J. Castillo Cardiovascular Fitness Is Negatively Associated With Homocysteine Levels in Female Adolescents Arch Pediatr Adolesc Med, February 1, 2007; 161(2): 166 - 171. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Groner, M. Joshi, and J. A. Bauer Pediatric Precursors of Adult Cardiovascular Disease: Noninvasive Assessment of Early Vascular Changes in Children and Adolescents Pediatrics, October 1, 2006; 118(4): 1683 - 1691. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Dinleyici, B. Kirel, O. Alatas, H. Muslumanoglu, Z. Kilic, and N. Dogruel Plasma Total Homocysteine Levels in Children with Type 1 Diabetes: Relationship with Vitamin Status, Methylene Tetrahydrofolate Reductase Genotype, Disease Parameters and Coronary Risk Factors J Trop Pediatr, August 1, 2006; 52(4): 260 - 266. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Ganji and M. R. Kafai Population References for Plasma Total Homocysteine Concentrations for U.S. Children and Adolescents in the Post-Folic Acid Fortification Era J. Nutr., September 1, 2005; 135(9): 2253 - 2256. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M van Beynum, M. den Heijer, C. M. Thomas, L. Afman, D. Oppenraay-van Emmerzaal, and H. J Blom Total homocysteine and its predictors in Dutch children Am. J. Clinical Nutrition, May 1, 2005; 81(5): 1110 - 1116. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Must, P. F. Jacques, G. Rogers, I. H. Rosenberg, and J. Selhub Serum Total Homocysteine Concentrations in Children and Adolescents: Results from the Third National Health and Nutrition Examination Survey (NHANES III) J. Nutr., August 1, 2003; 133(8): 2643 - 2649. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Bjorke Monsen and P. M. Ueland Homocysteine and methylmalonic acid in diagnosis and risk assessment from infancy to adolescence Am. J. Clinical Nutrition, July 1, 2003; 78(1): 7 - 21. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.D. Kark, R. Sinnreich, I.H. Rosenberg, P.F. Jacques, and J. Selhub Plasma Homocysteine and Parental Myocardial Infarction in Young Adults in Jerusalem Circulation, June 11, 2002; 105(23): 2725 - 2729. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Laskowska-Klita, E. Szymczak, and B. Radomyska Serum Homocysteine and Lipoprotein (a) Concentrations in Hypercholesterolemic and Normocholesterolemic Children Clinical Pediatrics, March 1, 2001; 40(3): 149 - 154. [Abstract] [PDF] |
||||
![]() |
G. Gaeta, M. De Michele, S. Cuomo, P. Guarini, M. C. Foglia, M. G. Bond, and M. Trevisan Arterial Abnormalities in the Offspring of Patients with Premature Myocardial Infarction N. Engl. J. Med., September 21, 2000; 343(12): 840 - 846. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M Ueland, H. Refsum, S. A. Beresford, and S. E. Vollset The controversy over homocysteine and cardiovascular risk Am. J. Clinical Nutrition, August 1, 2000; 72(2): 324 - 332. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |